MONDAY, Nov. 10, 2025 (HealthDay News) — Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the brain and spinal cord, with 2.9 million people estimated to be living with the disease worldwide. As MS is an autoimmune disease, damage is caused by inappropriate actions of theContinue Reading
FRIDAY, Oct. 3, 2025 (HealthDay News) — Menopause does not increase symptoms and disability among women with multiple sclerosis, a major new study has concluded. Some experts had been concerned that fluctuating hormone levels associated with menopause might affect severity of the neurodegenerative disease, researchers said. MS disability notably increasesContinue Reading
WEDNESDAY, Oct. 1, 2025 (HealthDay News) — The early warning signs of multiple sclerosis appear to be the same for everyone, regardless of their background. The pain, mood changes, brain decline and neurological problems associated with early MS can appear years before diagnosis, but appear to affect all types ofContinue Reading
FRIDAY, Sept. 26, 2025 (HealthDay News) — Ultra-processed foods could be making matters worse for people in the early throes of multiple sclerosis (MS), a new study says. Higher consumption of ultra-processed eats is linked to more frequent relapses in early MS patients, researchers reported Thursday at the annual meetingContinue Reading
THURSDAY, Sept. 18, 2025 (HealthDay News) — Nearly 4 out of 5 American neurologists prescribing multiple sclerosis (MS) drugs have received at least one payment from the pharmaceutical industry, a new study reports. Those who prescribe larger amounts of MS drugs were more likely to have received payments, and thoseContinue Reading
TUESDAY, Aug. 5, 2025 (HealthDay News) — Multiple sclerosis (MS) patients might have a higher risk of relapse if their health insurance is stingy with prescriptions, a new study reports. Patients with insurance plans that exclude coverage of some MS treatments have a significantly higher risk of developing new orContinue Reading
MONDAY, Aug. 4, 2025 (HealthDay News) — People with multiple sclerosis (MS) begin experiencing new health issues up to 15 years before the classic signs of the illness appear, Canadian research shows. “MS can be difficult to recognize as many of the earliest signs — like fatigue, headache, pain andContinue Reading
THURSDAY, July 31, 2025 (HealthDay News) — Women are less likely than men to receive multiple sclerosis (MS) meds that could help them manage the disease and delay disability, a new report finds. It could be that some women in their childbearing years are hesitant to use certain drugs inContinue Reading
WEDNESDAY, June 25, 2025 (HealthDay News) — People living with an autoimmune disease are nearly twice as likely to suffer from mood problems like depression, anxiety or bipolar disorder, a new large-scale study says. The risk of mood disorders is 87% to 97% higher in people suffering from rheumatoid arthritis,Continue Reading
TUESDAY, June 24, 2025 (HealthDay News) — A blood test might predict when multiple sclerosis patients are about to suffer a relapse in their symptoms, a new study says. Blood levels of a protein called neurofilament light chain rise significantly in MS patients up to a year before they haveContinue Reading
MONDAY, June 16, 2025 (HealthDay News) — Kids with multiple sclerosis (MS) age at an accelerated rate as the disease causes advanced wear and tear on their bodies, a new study says. This accelerated aging extends into their teenage years, increasing their odds that MS-related disability and chronic disease willContinue Reading
MONDAY, May 19, 2025 (HealthDay News) — Artificial intelligence (AI) can help detect when a person’s multiple sclerosis (MS) has reached an advanced state, a new study says. A newly developed AI correctly judged with 90% accuracy when a person’s MS had transitioned to a stage where it will progressContinue Reading
WEDNESDAY, April 9, 2025 (HealthDay News) — An experimental drug can help patients with advanced multiple sclerosis (MS) delay the progressive disability that comes with their disorder, a new clinical trial suggests. The drug, tolebrutinib, delayed disability progression by 31% in people with a type of MS called non-relapsing secondaryContinue Reading
WEDNESDAY, Feb. 26, 2025 (HealthDay News) — A diet rich in fish might slow the progression of multiple sclerosis in some patients, a new study says. The nutrients found in fish can quell inflammation and protect brain cells, and this might be of particular benefit for MS patients, researchers reportedContinue Reading